Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Vanguard

Vanguard Mid-Cap Value Index Fund Admiral Shares (VMVAX)

Ticker VMVAX · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.07%$7/yr per $10k
5-yr return
+10.7%annualized
1-yr return
+12.0%as of Dec 2025
Net assets
$37.2Ball share classes
Holdings
182

Bottom line

Is VMVAX a good fund? The bottom line

VMVAX is the Admiral share class of Vanguard Mid-Cap Value Index Fund, an index mid-cap mutual fund from Vanguard.

Its expense ratio is 0.07% — about $7 a year on every $10,000 invested, cheaper than 96% of mid-cap funds we track.

It returned +12.0% over one year, +10.7% a year over five years, +9.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $37.2 billion in net assets and 182 holdings, its largest position is Cummins Inc (1.7%) and the top 10 make up 12.6% of the portfolio.

What stands out

  • Low cost: cheaper than 96% of mid-cap peers
  • 5-year return beat 86% of category peers
  • No front-end sales load
  • Large and established ($37.2 billion)

Updated Nov 19, 2026

What VMVAX invests in

Vanguard Mid-Cap Value ETF, an exchange-traded share class of Vanguard Mid-Cap Value Index Fund (the Fund), seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization value stocks.

The Fund employs an indexing investment approach designed to track the performance of the CRSP US Mid Cap Value Index (the Target Index), a broadly diversified index of value stocks of mid-size U.S. companies, as determined by the index provider. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the Target Index. The Fund attempts to replicate the Target Index by investing all, or substantially all, of its assets in the stocks that make up the Target Index, holding each stock in approximately the same proportion as its weighting in the Target Index.

From the fund's prospectus (filed Apr 28, 2026).

VMVAX performance

Fund calendar-year total returns, 2018–2025 2018: −12.4%; 2019: +28.0%; 2020: +2.5%; 2021: +28.8%; 2022: −7.9%; 2023: +9.8%; 2024: +14.0%; 2025: +12.0% −12% 2018 +28% 2019 +3% 2020 +29% 2021 −8% 2022 +10% 2023 +14% 2024 +12% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VMVAX+12.0%+10.7%+9.9%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full VMVAX performance history →

What VMVAX costs

On a $10,000 investment, VMVAX's 0.07% expense ratio costs about $7 a year. The prospectus estimates $90 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full VMVAX fee table →

VMVAX top 10 holdings

#Holding% of fund
1Cummins Inc1.70%
2Valero Energy Corp1.33%
3Marathon Petroleum Corp1.29%
4Crh Plc1.23%
5United Rentals Inc1.22%
6SLB Ltd1.20%
7General Motors Co1.20%
8Simon Property Group Inc1.19%
9Phillips 661.17%
10Warner Bros Discovery Inc1.10%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 12.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to VMVAX

More funds like VMVAX →

VMVAX FAQ

What is the expense ratio of VMVAX?
VMVAX's expense ratio is 0.07%, which works out to about $7 a year for every $10,000 invested. The prospectus estimates total costs of $90 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VMVAX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 96% of mid-cap peers; 5-year return beat 86% of category peers; no front-end sales load; large and established ($37.2 billion). This is general information, not personalized advice.
What does VMVAX hold?
VMVAX's largest holdings are Cummins Inc (1.7%), Valero Energy Corp (1.3%), Marathon Petroleum Corp (1.3%), Crh Plc (1.2%), United Rentals Inc (1.2%). It holds 182 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is VMVAX's 5-year return?
VMVAX returned +10.7% a year over the five years ending Dec 31, 2025, and +9.9% a year over ten years. Past performance does not guarantee future results.
Does VMVAX have a sales load?
No. VMVAX has no front-end sales charge.
Is there an ETF version of VMVAX?
Yes — VOE is the ETF share class of the same fund, so it holds the same portfolio. Its expense ratio is 0.05%.
Who manages VMVAX?
VMVAX is offered by Vanguard through Vanguard Index Funds.